<DOC>
	<DOCNO>NCT02862262</DOCNO>
	<brief_summary>A three-arm , multi-site clinical evaluation ARIES Bordetella Assay detection identification Bordetella pertussis ( B. pertussis ) Bordetella parapertussis ( B. parapertussis ) nucleic acid prospectively collect , de-identified , left-over clinical specimen ; bank , pre-selected clinical specimen ; contrive specimen .</brief_summary>
	<brief_title>A Multi-Site Clinical Evaluation ARIES Bordetella Assay Symptomatic Patients</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Bordetella Infections</mesh_term>
	<criteria>1 . The specimen nasopharyngeal swab collect use cleared nasopharyngeal swab transport medium . 2 . The specimen adult pediatric , male female subject either hospitalize , admit hospital emergency department , visit outpatient clinica resident long term care facility . 3 . The specimen patient requisition make B. pertussis and/or B. parapertussis test . 4 . The specimen patient exhibit clinical sign symptom respiratory tract infection consistent B. pertussis B. parapertussis . 5 . The specimen receive good condition ( leakage dry specimen ) . 6 . The specimen contain minimum volume 1000 μL . 1 . The specimen nasopharyngeal swab collect use cleared nasopharyngeal swab transport medium . 2 . The specimen properly collect , transport , process store accord instruction provide Sponsor Section 10 . 3 . The specimen volume &lt; 1000 μL . 4 . Any specimen test per complete test algorithm provide Sponsor .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>